Factors of coronary artery disease unfavorable clinical course in Yakutia residents
Abstract
In our research we have tried by means of complex clinical-functional and angiographic inspections to ascertain factors of unfavorable CAD course in the remote 7-year period.
About the Authors
T. A. RomanovaRussian Federation
Yakutsk
M. I. Voevoda
Russian Federation
Novosibirsk;
Yakutsk
I. R. Petrova
Russian Federation
Yakutsk
L. V. Tarabukina
Russian Federation
Yakutsk
T. Ju. Tomskaja
Russian Federation
Yakutsk
References
1. The State report on a health state of the Republic Sakha (Yakutia) population in 2008 Ministry of Health Republic Sakha (Yakutia); Yakut republican medical information-analytical centre. - Yakutsk: Company «Dani Almas», 2009.-120 p.
2. Ivanov K.I. Features of CAD epidemiology and its risk factors in Yakutia / K.I. Ivanov, T.M. Klimova, V.P. Alekseev, V.G. Krivoshapkin.- Yakutsk, 2008. - 90 p.
3. Konstantinov V.V. Risk factors, CAD and atherosclerosis among men of indigenous and non- indigenous nationality in cities of some regions/V.V.Konstantinov, G.S. Zhukovsky, V.S. Zhdanov//Kardiologija. - 1997. - №6. - P. 19-23.
4. Prognostic value of indexes of left ventricle contractile function at the prospective one-year follow-up over the patients who had anterior myocardial infarction / Chikvashvili D.I. [et.al.] // Kardiologija. - 1994.- Vol. 34, №1. - P.7-10.
5. Sumarokov A.B. Risk stratification of ischemic heart disease patients / A.B. Sumarokov //RMZH. - 1998. - №6. - P. 896-907
6. Tetyorkina T.V. Dynamics of clinical and structurally-functional parameters of heart in the patients who had myocardial infarction, by results of 5-year follow-up: abstract of a thesis on Ph degree/T.V.Tetyorkina. - Tomsk, 2009. - 30 p.
7. Chepurina N.A. Assessment of prognostic significance of total cardiovascular risk and factors, its defining, in a cohort of men - state employees (clinic-epidemiological research): abstract of a thesis on Ph degree / N.A. Chepurina. – M., 2009. - 24 p.
8. Australia. New Zealand Heart Failure Research Collaborative Group. Randomized placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease// Lancet. – 1997. - V. 349. – P. 375-380.
9. Lipid lowening and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease / B.G. Brown [et al.] // Circulation. – 1993. - V. 87. – P.1781-1791.
10. Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA-2) trial// Lancet. - 1997.- V. 350 – P461-468.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesrerol lowening in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)//Lancet. – 1994. – V. 344 – P. 1383-1389.
12. The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease // N. Engl. J. Med. – 2009. - V. 360. - P2503-2515.
13. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels / F.M. Sacks [et al.] // N. Engl. J. Med. - 1996. - V. 335- P.1001- 1009.
Review
For citations:
Romanova T.A., Voevoda M.I., Petrova I.R., Tarabukina L.V., Tomskaja T.J. Factors of coronary artery disease unfavorable clinical course in Yakutia residents. Yakut Medical Journal. 2011;(4):18-22.








